PatientMatch — Privacy-first clinical trial discovery

148 trials

Ovarian CancerRecruiting now

Enrolling now24

Nationwide

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

National Cancer Institute (NCI)

Ph 2·~5yr·1 site in MD

Enrolling now

12q~3min

Check if I qualify View study

Nationwide

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

Merck Sharp & Dohme LLC

Ph 3·1 site in FL

Enrolling now

9q~2min

Check if I qualify View study

Nationwide

A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors

Qurgen Inc.

Ph 1·~3yr·5 sites in AZ, MI, NC +2

Enrolling now

12q~3min

Check if I qualify View study

Nationwide

A Phase 1 Trial of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors

Context Therapeutics Inc.

Ph 1·~4yr·13 sites in AR, CA, CO +10

Enrolling now

7q~2min

Check if I qualify View study

Nationwide

A Phase 1/2 Trial of TER-2013

Terremoto Biosciences Inc.

Ph 1/2·~3yr·14 sites in FL, MA, MN +9

Enrolling now

11q~3min

Check if I qualify View study

Nationwide

A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)

Memorial Sloan Kettering Cancer Center

~4yr·7 sites in NJ, NY

Enrolling now

12q~3min

Check if I qualify View study

Nationwide

A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer

Memorial Sloan Kettering Cancer Center

~5yr·7 sites in NJ, NY

Enrolling now

8q~2min

Check if I qualify View study

Nationwide

A Study of ART0380 for Advanced Cancer

Artios Pharma Ltd

Ph 1/2·~6yr·40 sites in AL, AR, AZ +18

Enrolling now

11q~3min

Check if I qualify View study

Nationwide

A Study of CBX-12 in Subjects With Platinum Resistant or Refractory Ovarian Cancer

Cybrexa Therapeutics

Ph 2·~13mo·17 sites in AZ, CA, CT +10

Enrolling now

8q~2min

Check if I qualify View study

Nationwide

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Clasp Therapeutics, Inc.

Ph 1·~3yr·21 sites in AZ, CA, FL +10

Enrolling now

8q~2min

Check if I qualify View study

Nationwide

A Study of Isoquercetin in People With Ovarian Cancer

Memorial Sloan Kettering Cancer Center

Ph 2·~6yr·8 sites in MA, NJ, NY

Enrolling now

13q~3min

Check if I qualify View study

Nationwide

A Study of Lorigerlimab in Participants With Advanced Solid Tumors

MacroGenics

Ph 2·~2yr·7 sites in CA, LA, MI +3

Enrolling now

12q~3min

Check if I qualify View study

Nationwide

A Study of ETX-19477 in Patients With Advanced Solid Malignancies

858 Therapeutics, Inc.

Ph 1/2·~3yr·14 sites in AZ, CT, FL +10

Enrolling now

15q~4min

Check if I qualify View study

Nationwide

A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

BeiGene

Ph 1·~4yr·6 sites in CA, FL, MO +3

Enrolling now

13q~3min

Check if I qualify View study

Nationwide

REGN5668 Trial for Ovarian Cancer

Regeneron Pharmaceuticals

Ph 1/2·~7yr·13 sites in CA, FL, IL +6

Enrolling now

9q~2min

Check if I qualify View study

Nationwide

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

NiKang Therapeutics, Inc.

Ph 1·~5yr·19 sites in AR, CA, CO +10

Enrolling now

13q~3min

Check if I qualify View study

Nationwide

Gene Transfer Trial for Cancer

National Cancer Institute (NCI)

Ph 1/2·~11yr·1 site in MD

Enrolling now

11q~3min

Check if I qualify View study

Nationwide

Gene Therapy Trial for Cancer

National Cancer Institute (NCI)

Ph 2·~10yr·1 site in MD

Enrolling now

11q~3min

Check if I qualify View study

Nationwide

Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells

UNC Lineberger Comprehensive Cancer Center

Ph 1·~1.5yr·1 site in NC

Enrolling now

9q~2min

Check if I qualify View study

Nationwide

CT-95 Trial for Advanced Cancers

Context Therapeutics Inc.

Ph 1·~4yr·7 sites in CO, IL, MI +4

Enrolling now

7q~2min

Check if I qualify View study

Nationwide

Decitabine and Selinexor in Combination to Reverse Drug Resistance With Standard Chemotherapy in Ovarian Cancer

Loyola University

Ph 2·~8yr·1 site in IL

Enrolling now

9q~2min

Check if I qualify View study

Nationwide

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.

Ph 1·2 sites in TX, UT

Enrolling now

9q~2min

Check if I qualify View study

Nationwide

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

Genelux Corporation

Ph 3·~4yr·31 sites in AL, AZ, CA +16

Enrolling now

13q~3min

Check if I qualify View study

Nationwide

Fasting During Neoadjuvant Chemotherapy

Case Comprehensive Cancer Center

~18mo·1 site in OH

Enrolling now

8q~2min

Check if I qualify View study